Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 2 - The Real Truth

3 Robotics Stocks Powering the Automation Revolution

Robotics is pivotal in the automation revolution, driving substantial growth in diverse sectors like air defense and healthcare. Therefore, it could be wise to consider fundamentally strong robotics stocks like RTX (RTX), Stryker (SYK), and Medtronic (MDT). Read on.

StockNews.com

Stryker - Growth Through Aggressive M&A

Summary Stryker Corporation (SYK) shows strong technical buy signals, with a 6.09% gain since 8/21, and consistent price appreciation across key moving averages. The company operates in MedSurg, Neurotechnology, Orthopaedics, and Spine segments, offering a wide range of medical devices and technologies. Analysts provide mixed ratings, with price targets ranging...

Barchart

Stryker Stock: Is SYK Outperforming the Healthcare Sector?

Despite Stryker’s outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Robotics Stocks to Watch for the Automation Revolution

The robotics industry’s long-term growth is fueled by rapid technological advancements and automation across several sectors. Thus, it could be wise to keep an eye on fundamentally solid robotics stocks Stryker (SYK), Honeywell International (HON), and Medtronic (MDT) to capitalize on the automation revolution. Keep reading….

StockNews.com

Are Wall Street Analysts Predicting Stryker Stock Will Climb or Sink?

Stryker has underperformed the broader market this year, but Wall Street analysts are moderately bullish about the stock’s prospects.

Barchart

3 MedTech Stocks Innovating Healthcare

MedTech’s bright future is fueled by rapid tech advancements and increasing demand for medical devices, implants, and precision treatments, driven by an aging population and rising global disease rates. Given this backdrop, adding strong MedTech stocks like Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) to one’s portfolio could be…

StockNews.com

Stryker’s Q2 2024 Earnings: What to Expect

Stryker will unveil its Q2 earnings later this month, and analysts project a single-digit profit growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 Healthcare Stocks Set to Benefit From Aging Population Trends

The healthcare industry is set to grow significantly due to technological advances, an aging population, and increasing demand for quality healthcare. To that end, it could be wise to buy fundamentally strong healthcare stocks like Abbott Laboratories (ABT), Stryker (SYK), and Centene (CNC), which are set to benefit from these…

StockNews.com

Is Stryker Stock Underperforming the Dow

Stryker has recently underperformed the Dow Jones, but Wall Street analysts anticipate a moderate upside for the stock.

Barchart

Danaher (DHR) vs. Stryker (SYK) - Analyzing Anticipated Q4 Earnings

With rapidly increasing healthcare demands, numerous technological breakthroughs, and advanced research and development, the medical industry is well-poised for remarkable growth and profitability. As medical companies Danaher (DHR) and Stryker (SYK) gear to report their fourth-quarter earnings tomorrow, let’s determine if these stocks are ideal buys ahead of earnings….

StockNews.com

1 Health Care Stock Hedge Funds Are Buying Right Now

Stryker (SYK) gained more than 8% over the past month. Moreover, it pays a reliable dividend. So, amid rising hedge funds’ interest in the stock, should you consider investing in SYK? Keep reading….

StockNews.com

If You Invested $100 In This Stock 15 Years Ago, You Would Have $300 Today

Stryker (NYSE:SYK) has outperformed the market over the past 15 years by 1.53% on an annualized basis producing an average annual return of 7.72%. Currently, Stryker has a market capitalization of $75.26 billion.

Benzinga

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,400 Today

Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 3.77% on an annualized basis producing an average annual return of 10.61%. Currently, Stryker has a market capitalization of $73.87 billion.

Benzinga

If You Invested $1000 In Stryker 10 Years Ago, Here's How Much You Would Have Today

Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 4.22% on an annualized basis producing an average annual return of 16.42%. Currently, Stryker has a market capitalization of $88.64 billion.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

6 Stocks To Buy That Are Near 52-Week Lows

Weakness in the S&P 500 has made life unpleasant for investors so far in 2022, but it has also created buying opportunities in a handful of high-quality stocks. Long-term investors looking to buy the dip can find plenty of stocks to buy that are at or near their lowest prices…

StockNews.com

Abbott vs. Stryker: Which Medical Devices Stock is a Better Investment?

Given the increasing investments in R&D and technological integrations, and the rebounding demand for critical surgical procedures, the medical devices industry is well-positioned to grow. This should benefit Abbott (ABT) and Stryker (SYK). But which of these stocks is a better buy now?.

StockNews.com

Are Medical Device Stocks Good Investments During a Recession?

The stock market has witnessed a massive sell-off lately on concerns over the Fed’s aggressive interest rate hikes to fight the decade-high inflation. Many analysts expect the economy to slip into recession due to the Fed’s monetary policy tightening. Since the medical device industry is known to be one of…

Benzinga

RBC Capital Remains On Sidelines For This MedTech Stock

Stryker Corporation (NYSE: SYK) reported 1Q FY22 results that beat on the top and bottom line, reflecting a solid rebound in procedure volumes in March.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Analyst Ratings for Stryker

Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:

Benzinga

Recap: Stryker Q1 Earnings

Stryker (NYSE:SYK) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Stryker beat estimated earnings by 1.03%, reporting an EPS of $1.97 versus an estimate of $1.95.

Benzinga

Analyst Ratings for Stryker

Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:

Benzinga

Analyst Ratings For Stryker

Stryker (NYSE:SYK) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings For Stryker

Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:

Benzinga

Stryker Posts Mixed Bag Q4 Earnings, Issues FY22 Guidance Below Consensus

Stryker Corp (NYSE: SYK) posted

Benzinga

Recap: Stryker Q4 Earnings

Stryker (NYSE:SYK) reported its Q4 earnings results on Thursday, January 27, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

1 2 3

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

James Ellis

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.